Wegovy
- All
- News
-
Popular Weight Loss Drug Ozempic Could Increase Risk Of Blindness, Study Says
Research reveals a link between Ozempic and Wegovy, popular weight loss and diabetes medications, and an increased risk of blindness.
-
Doctors Warn Against Taking Weight-Loss Drug For 'Beach Body': "Not A Quick Fix"
Recently, Ozempic has been repurposed for weight loss, marketed under the brand name Wegovy, after clinical trials demonstrated its effectiveness in significantly reducing body weight.
-
Diabetes, Weight Loss Medications Linked To Increased Risk Of Stomach Paralysis: Study
Popular diabetes and weight loss medications like Ozempic and Wegovy have been linked with an increased risk of developing stomach paralysis, new studies have found.
-
Weight Loss Drugs Slash Heart Attack Risk, Says Study
Research showed promising results for semaglutide (Wegovy) in reducing heart risks for obese patients already battling cardiovascular diseases.
-
New Weight-Loss Medicine That Dampens Appetite Is Flying Off The Shelves
In a field starved for options, demand is exceeding supply for Wegovy, a weekly injection launched in June that dampens patients' appetite and helps them to lose about 15 per cent of their body weight.
-
Popular Weight Loss Drug Ozempic Could Increase Risk Of Blindness, Study Says
Research reveals a link between Ozempic and Wegovy, popular weight loss and diabetes medications, and an increased risk of blindness.
-
Doctors Warn Against Taking Weight-Loss Drug For 'Beach Body': "Not A Quick Fix"
Recently, Ozempic has been repurposed for weight loss, marketed under the brand name Wegovy, after clinical trials demonstrated its effectiveness in significantly reducing body weight.
-
Diabetes, Weight Loss Medications Linked To Increased Risk Of Stomach Paralysis: Study
Popular diabetes and weight loss medications like Ozempic and Wegovy have been linked with an increased risk of developing stomach paralysis, new studies have found.
-
Weight Loss Drugs Slash Heart Attack Risk, Says Study
Research showed promising results for semaglutide (Wegovy) in reducing heart risks for obese patients already battling cardiovascular diseases.
-
New Weight-Loss Medicine That Dampens Appetite Is Flying Off The Shelves
In a field starved for options, demand is exceeding supply for Wegovy, a weekly injection launched in June that dampens patients' appetite and helps them to lose about 15 per cent of their body weight.
